{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:25:49Z","timestamp":1768317949764,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T00:00:00Z","timestamp":1457568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T00:00:00Z","timestamp":1457568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL119828"],"award-info":[{"award-number":["R01-HL119828"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL055798"],"award-info":[{"award-number":["R01-HL055798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL088093"],"award-info":[{"award-number":["R01-HL088093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL106579"],"award-info":[{"award-number":["R01-HL106579"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL078610"],"award-info":[{"award-number":["R01-HL078610"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL124174"],"award-info":[{"award-number":["R01-HL124174"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PBBSP3-124742"],"award-info":[{"award-number":["PBBSP3-124742"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Schweizerischen Stiftung f\u00fcr medizinisch-biologische Stipendien","award":["PASMP3_132566"],"award-info":[{"award-number":["PASMP3_132566"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11239-016-1351-6","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T15:58:21Z","timestamp":1457625501000},"page":"569-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina"],"prefix":"10.1007","volume":"41","author":[{"given":"Gregor","family":"Leibundgut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley H.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,10]]},"reference":[{"issue":"18","key":"1351_CR1","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1161\/01.CIR.0000066695.24697.07","volume":"107","author":"F Prati","year":"2003","unstructured":"Prati F, Pawlowski T, Gil R, Labellarte A, Gziut A, Caradonna E et al (2003) Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study. Circulation. 107(18):2320\u20132325","journal-title":"Circulation."},{"issue":"63","key":"1351_CR2","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.jacc.2014.01.055","volume":"21","author":"A Ravandi","year":"2014","unstructured":"Ravandi A, Leibundgut G, Hung M-Y, Patel M, Hutchins PM, Murphy RC et al (2014) Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans. J Am Coll Cardiol 21(63):1961\u20131971","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"1351_CR3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jacc.2012.11.068","volume":"61","author":"RP Juni","year":"2013","unstructured":"Juni RP, Duckers HJ, Vanhoutte PM, Virmani R, Moens AL (2013) Oxidative stress and pathological changes after coronary artery interventions. J Am Coll Cardiol 61(14):1471\u20131481","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1351_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/hc0502.102966","volume":"105","author":"JM Breuss","year":"2002","unstructured":"Breuss JM, Cejna M, Bergmeister H, Kadl A, Baumgartl G, Steurer S et al (2002) Activation of nuclear factor-\u03baB significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation 105(5):633\u2013638","journal-title":"Circulation"},{"issue":"12","key":"1351_CR5","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1194\/jlr.P030890","volume":"53","author":"RA van Dijk","year":"2012","unstructured":"van Dijk RA, Kolodgie F, Ravandi A, Leibundgut G, Hu PP, Prasad A et al (2012) Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions. J Lipid Res 53(12):2773\u20132790","journal-title":"J Lipid Res"},{"issue":"12","key":"1351_CR6","doi-asserted-by":"publisher","first-page":"e83145","DOI":"10.1371\/journal.pone.0083145","volume":"8","author":"S-H Choi","year":"2013","unstructured":"Choi S-H, Yin H, Ravandi A, Armando A, Dumlao D, Kim J et al (2013) Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages. PLoS One 8(12):e83145","journal-title":"PLoS One"},{"issue":"25","key":"1351_CR7","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","volume":"109","author":"S Tsimikas","year":"2004","unstructured":"Tsimikas S, Lau HK, Han K-R, Shortal B, Miller ER, Segev A et al (2004) Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109(25):3164\u20133170","journal-title":"Circulation"},{"issue":"1","key":"1351_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.carrev.2011.08.001","volume":"13","author":"P Fefer","year":"2012","unstructured":"Fefer P, Tsimikas S, Segev A, Sparkes J, Otsuma F, Kolodgie F et al (2012) The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization. Cardiovasc Revasc Med. 13(1):11\u201319","journal-title":"Cardiovasc Revasc Med."},{"issue":"5","key":"1351_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ahj.2004.12.008","volume":"150","author":"A Segev","year":"2005","unstructured":"Segev A, Strauss BH, Witztum JL, Lau HK, Tsimikas S (2005) Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina. Am Heart J 150(5):1007\u20131014","journal-title":"Am Heart J"},{"issue":"11","key":"1351_CR10","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","volume":"47","author":"S Tsimikas","year":"2006","unstructured":"Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F et al (2006) Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. J Am Coll Cardiol 47(11):2219\u20132228","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"1351_CR11","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.jacc.2011.12.033","volume":"59","author":"G Leibundgut","year":"2012","unstructured":"Leibundgut G, Arai K, Orsoni A, Yin H, Scipione C, Miller ER et al (2012) Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction. J Am Coll Cardiol. 59(16):1426\u20131437","journal-title":"J Am Coll Cardiol."},{"issue":"15","key":"1351_CR12","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1161\/01.CIR.100.15.1616","volume":"100","author":"BH Strauss","year":"1999","unstructured":"Strauss BH, Lau HK, Bowman KA, Sparkes J, Chisholm RJ, Garvey MB et al (1999) Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation 100(15):1616\u20131622","journal-title":"Circulation"},{"issue":"5","key":"1351_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/bmm.11.60","volume":"5","author":"A Taleb","year":"2011","unstructured":"Taleb A, Witztum JL, Tsimikas S (2011) Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events. Biomark Med 5(5):673\u2013694","journal-title":"Biomark Med"},{"issue":"21","key":"1351_CR14","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.jacc.2013.02.047","volume":"61","author":"ML Bertoia","year":"2013","unstructured":"Bertoia ML, Pai JK, Lee J-H, Taleb A, Joosten MM, Mittleman MA et al (2013) Oxidation-specific biomarkers and risk of peripheral artery disease. J Am Coll Cardiol 61(21):2169\u20132179","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1351_CR15","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","volume":"66","author":"R Capoulade","year":"2015","unstructured":"Capoulade R, Chan KL, Yeang C, Mathieu P, Boss\u00e9 Y, Dumesnil JG et al (2015) Oxidized phospholipids, lipoprotein(a),\u00a0and progression of calcific\u00a0aortic valve\u00a0stenosis. J Am Coll Cardiol 66(11):1236\u20131246","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"1351_CR16","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jacc.2015.01.050","volume":"65","author":"YS Byun","year":"2015","unstructured":"Byun YS, Lee J-H, Arsenault BJ, Yang X, Bao W, DeMicco D et al (2015) Relationship of oxidized phospholipids on\u00a0apolipoprotein B-100 to cardiovascular\u00a0outcomes in patients treated with intensive versus moderate\u00a0atorvastatin therapy: the TNT trial. J Am Coll Cardiol 65(13):1286\u20131295","journal-title":"J Am Coll Cardiol"},{"issue":"7367","key":"1351_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nature10449","volume":"478","author":"D Weismann","year":"2011","unstructured":"Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HPN, Charbel Issa P et al (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478(7367):76\u201381","journal-title":"Nature"},{"key":"1351_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-pathol-020712-163936","volume":"9","author":"JL Witztum","year":"2014","unstructured":"Witztum JL, Lichtman AH (2014) The influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol 9:73\u2013102","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"1351_CR19","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jacc.2010.04.048","volume":"56","author":"S Tsimikas","year":"2010","unstructured":"Tsimikas S, Mallat Z, Talmud PJ, Kastelein JJP, Wareham NJ, Sandhu MS et al (2010) Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events. J Am Coll Cardiol 56(12):946\u2013955","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1351_CR20","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/ATVBAHA.107.145805","volume":"27","author":"S Kiechl","year":"2007","unstructured":"Kiechl S, Willeit J, Mayr M, Viehweider B, Oberhollenzer M, Kronenberg F et al (2007) Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Arterioscler Thromb Vasc Biol 27(8):1788\u20131795","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"1351_CR21","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.jacc.2005.12.047","volume":"47","author":"J Rodenburg","year":"2006","unstructured":"Rodenburg J, Vissers MN, Wiegman A, Miller ER, Ridker PM, Witztum JL et al (2006) Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin. J Am Coll Cardiol 47(9):1803\u20131810","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1351_CR22","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1194\/jlr.M025445","volume":"53","author":"S Amir","year":"2012","unstructured":"Amir S, Hartvigsen K, Gonen A, Leibundgut G, Que X, Jensen-Jarolim E et al (2012) Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease. J Lipid Res 53(7):1316\u20131326","journal-title":"J Lipid Res"},{"issue":"12","key":"1351_CR23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.ehj.2004.04.027","volume":"25","author":"A Segev","year":"2004","unstructured":"Segev A, Kassam S, Buller CE, Lau HK, Sparkes JD, Connelly PW et al (2004) Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Eur Heart J 25(12):1029\u20131035","journal-title":"Eur Heart J"},{"issue":"3","key":"1351_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","volume":"41","author":"S Tsimikas","year":"2003","unstructured":"Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E et al (2003) Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41(3):360\u2013370","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"1351_CR25","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1161\/CIRCULATIONAHA.109.888784","volume":"120","author":"G Heusch","year":"2009","unstructured":"Heusch G, Kleinbongard P, B\u00f6se D, Levkau B, Haude M, Schulz R et al (2009) Coronary microembolization: from bedside to bench and back to bedside. Circulation 120(18):1822\u20131836","journal-title":"Circulation"},{"issue":"2","key":"1351_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2004.04.036","volume":"44","author":"H Sato","year":"2004","unstructured":"Sato H, Iida H, Tanaka A, Tanaka H, Shimodouzono S, Uchida E et al (2004) The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. J Am Coll Cardiol 44(2):300\u2013304","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1351_CR27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jacc.2005.10.053","volume":"47","author":"K Leineweber","year":"2006","unstructured":"Leineweber K, B\u00f6se D, Vogelsang M, Haude M, Erbel R, Heusch G (2006) Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts. J Am Coll Cardiol 47(5):981\u2013986","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1351_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/1522-726X(200009)51:1<42::AID-CCD10>3.0.CO;2-A","volume":"51","author":"Y Hojo","year":"2000","unstructured":"Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fukazawa H, Kurosaki K et al (2000) Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty. Catheter Cardiovasc Interv 51(1):42\u201349","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"1351_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0735-1097(97)00237-4","volume":"30","author":"V Schachinger","year":"1997","unstructured":"Schachinger V, Halle M, Minners J, Berg A, Zeiher AM (1997) Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Coll Cardiol 30(4):927\u2013934","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1351_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/0049-3848(80)90214-5","volume":"18","author":"MJ Gallimore","year":"1980","unstructured":"Gallimore MJ, Aasen AO, Erichsen NS, Larsbraaten M, Lyngaas K, Amundsen E (1980) Plasminogen concentrations and functional activities and concentrations of plasmin inhibitors in plasma samples from normal subjects and patients with septic shock. Thromb Res 18(5):601\u2013608","journal-title":"Thromb Res"},{"issue":"3","key":"1351_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.survophthal.2009.11.001","volume":"55","author":"LA Donoso","year":"2010","unstructured":"Donoso LA, Vrabec T, Kuivaniemi H (2010) The role of complement factor H in age-related macular degeneration: a review. Surv Ophthalmol 55(3):227\u2013246","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"1351_CR32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/eurheartj\/ehn568","volume":"30","author":"KCMC Koeijvoets","year":"2009","unstructured":"Koeijvoets KCMC, Mooijaart SP, Dallinga-Thie GM, Defesche JC, Steyerberg EW, Westendorp RGJ et al (2009) Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia. Eur Heart J 30(5):618\u2013623","journal-title":"Eur Heart J"},{"issue":"1","key":"1351_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2010.07.021","volume":"213","author":"R Sofat","year":"2010","unstructured":"Sofat R, Casas JP, Kumari M, Talmud PJ, Ireland H, Kivimaki M et al (2010) Genetic variation in complement factor H and risk of coronary heart disease: eight new studies and a meta-analysis of around 48,000 individuals. Atherosclerosis. 213(1):184\u2013190","journal-title":"Atherosclerosis."},{"issue":"11","key":"1351_CR34","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/eurheartj\/ehm090","volume":"28","author":"JK Pai","year":"2007","unstructured":"Pai JK, Manson JE, Rexrode KM, Albert CM, Hunter DJ, Rimm EB (2007) Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women. Eur Heart J 28(11):1297\u20131303","journal-title":"Eur Heart J"},{"key":"1351_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2350-8-62","volume":"8","author":"W Meng","year":"2007","unstructured":"Meng W, Hughes A, Patterson CC, Belton C, Kamaruddin MS, Horan PG et al (2007) Genetic variants of complement factor H gene are not associated with premature coronary heart disease: a family-based study in the Irish population. BMC Med Genet 8:62","journal-title":"BMC Med Genet"},{"issue":"3","key":"1351_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-0463.2005.apm1130303.x","volume":"113","author":"K Iltumur","year":"2005","unstructured":"Iltumur K, Karabulut A, Toprak G, Toprak N (2005) Complement activation in acute coronary syndromes. APMIS. 113(3):167\u2013174","journal-title":"APMIS."},{"issue":"2","key":"1351_CR37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.molimm.2014.02.012","volume":"59","author":"J Ferluga","year":"2014","unstructured":"Ferluga J, Kishore U, Sim RB (2014) A potential anti-coagulant role of complement factor H. Mol Immunol 59(2):188\u2013193","journal-title":"Mol Immunol"},{"issue":"6","key":"1351_CR38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.ATV.18.6.984","volume":"18","author":"R Ramharack","year":"1998","unstructured":"Ramharack R, Barkalow D, Spahr MA (1998) Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol 18(6):984\u2013990","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1351_CR39","first-page":"1","volume":"2015","author":"AP DeFilippis","year":"2015","unstructured":"DeFilippis AP, Chernyavskiy I, Amraotkar AR, Trainor PJ, Kothari S, Ismail I et al (2015) Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction. J Thromb Thrombolysis. 2015:1\u20136","journal-title":"J Thromb Thrombolysis."},{"key":"1351_CR40","first-page":"1","volume":"2013","author":"G Leibundgut","year":"2013","unstructured":"Leibundgut G, Witztum JL, Tsimikas S (2013) Oxidation-specific epitopes and immunological responses: translational biotheranostic implications for atherosclerosis. Curr Opin Pharmacol. 2013:1\u201312","journal-title":"Curr Opin Pharmacol."},{"issue":"21","key":"1351_CR41","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","volume":"60","author":"S Tsimikas","year":"2012","unstructured":"Tsimikas S, Willeit P, Willeit J, Santer P, Mayr M, Xu Q et al (2012) Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. J Am Coll Cardiol 60(21):2218\u20132229","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"1351_CR42","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.jacc.2013.12.030","volume":"63","author":"S Tsimikas","year":"2014","unstructured":"Tsimikas S, Duff GW, Berger PB, Rogus J, Huttner K, Clopton P et al (2014) Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). J Am Coll Cardiol 63(17):1724\u20131734","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1351_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s12265-014-9590-4","volume":"7","author":"K Briley-Saebo","year":"2014","unstructured":"Briley-Saebo K, Yeang C, Witztum JL, Tsimikas S (2014) Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions. J Cardiovasc Transl Res. 7(8):719\u2013736","journal-title":"J Cardiovasc Transl Res."},{"issue":"6","key":"1351_CR44","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nm876","volume":"9","author":"CJ Binder","year":"2003","unstructured":"Binder CJ, Horkko S, Dewan A, Chang M-K, Kieu EP, Goodyear CS et al (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9(6):736\u2013743","journal-title":"Nat Med"},{"issue":"16","key":"1351_CR45","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jacc.2011.07.017","volume":"58","author":"S Tsimikas","year":"2011","unstructured":"Tsimikas S, Miyanohara A, Hartvigsen K, Merki E, Shaw PX, Chou M-Y et al (2011) Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol 58(16):1715\u20131727","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1351_CR46","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1172\/JCI57755","volume":"121","author":"L Fang","year":"2011","unstructured":"Fang L, Green SR, Baek JS, Lee S-H, Ellett F, Deer E et al (2011) In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish. J Clin Invest. 121(12):4861\u20134869","journal-title":"J Clin Invest."}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-016-1351-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1351-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:57:14Z","timestamp":1589702234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-016-1351-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["1351"],"URL":"https:\/\/doi.org\/10.1007\/s11239-016-1351-6","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,10]]},"assertion":[{"value":"10 March 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Tsimikas is a co-inventor and receives royalties for patents owned by the University of California for the clinical use of oxidation-specific antibodies and currently holds a dual appointment at UCSD and as an employee of Ionis Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}